Cargando…

Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis

BACKGROUND: Sterol biosynthesis is an essential pathway for fungal survival, and is the biochemical target of many antifungal agents. The antifungal drugs most widely used to treated fungal infections are compounds that inhibit cytochrome P450-dependent C14α-demethylase (CYP51), but other enzymes of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishida, Kelly, Fernandes Rodrigues, Juliany Cola, Cammerer, Simon, Urbina, Julio A, Gilbert, Ian, de Souza, Wanderley, Rozental, Sonia
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3036746/
https://www.ncbi.nlm.nih.gov/pubmed/21255433
http://dx.doi.org/10.1186/1476-0711-10-3
_version_ 1782197896784904192
author Ishida, Kelly
Fernandes Rodrigues, Juliany Cola
Cammerer, Simon
Urbina, Julio A
Gilbert, Ian
de Souza, Wanderley
Rozental, Sonia
author_facet Ishida, Kelly
Fernandes Rodrigues, Juliany Cola
Cammerer, Simon
Urbina, Julio A
Gilbert, Ian
de Souza, Wanderley
Rozental, Sonia
author_sort Ishida, Kelly
collection PubMed
description BACKGROUND: Sterol biosynthesis is an essential pathway for fungal survival, and is the biochemical target of many antifungal agents. The antifungal drugs most widely used to treated fungal infections are compounds that inhibit cytochrome P450-dependent C14α-demethylase (CYP51), but other enzymes of this pathway, such as squalene synthase (SQS) which catalyses the first committed step in sterol biosynthesis, could be viable targets. The aim of this study was to evaluate the antifungal activity of SQS inhibitors on Candida albicans, Candida tropicalis and Candida parapsilopsis strains. METHODS: Ten arylquinuclidines that act as SQS inhibitors were tested as antiproliferative agents against three ATCC strains and 54 clinical isolates of Candida albicans, Candida tropicalis and Candida parapsilopsis. Also, the morphological alterations induced in the yeasts by the experimental compounds were evaluated by fluorescence and transmission electron microscopy. RESULTS: The most potent arylquinuclidine derivative (3-[1'-{4'-(benzyloxy)-phenyl}]-quinuclidine-2-ene) (WSP1267) had a MIC(50 )of 2 μg/ml for all species tested and MIC(90 )varying from 4 μg/ml to 8 μg/ml. Ultrathin sections of C. albicans treated with 1 μg/ml of WSP1267 showed several ultrastructural alterations, including (a) loss of cell wall integrity, (b) detachment of the plasma membrane from the fungal cell wall, (c) accumulation of small vesicles in the periplasmic region, (d) presence of large electron-dense vacuoles and (e) significantly increased cell size and cell wall thickness. In addition, fluorescence microscopy of cells labelled with Nile Red showed an accumulation of lipid droplets in the cytoplasm of treated yeasts. Nuclear staining with DAPI revealed the appearance of uncommon yeast buds without a nucleus or with two nuclei. CONCLUSION: Taken together, our data demonstrate that arylquinuclidine derivatives could be useful as lead compounds for the rational synthesis of new antifungal drugs.
format Text
id pubmed-3036746
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30367462011-02-10 Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis Ishida, Kelly Fernandes Rodrigues, Juliany Cola Cammerer, Simon Urbina, Julio A Gilbert, Ian de Souza, Wanderley Rozental, Sonia Ann Clin Microbiol Antimicrob Research BACKGROUND: Sterol biosynthesis is an essential pathway for fungal survival, and is the biochemical target of many antifungal agents. The antifungal drugs most widely used to treated fungal infections are compounds that inhibit cytochrome P450-dependent C14α-demethylase (CYP51), but other enzymes of this pathway, such as squalene synthase (SQS) which catalyses the first committed step in sterol biosynthesis, could be viable targets. The aim of this study was to evaluate the antifungal activity of SQS inhibitors on Candida albicans, Candida tropicalis and Candida parapsilopsis strains. METHODS: Ten arylquinuclidines that act as SQS inhibitors were tested as antiproliferative agents against three ATCC strains and 54 clinical isolates of Candida albicans, Candida tropicalis and Candida parapsilopsis. Also, the morphological alterations induced in the yeasts by the experimental compounds were evaluated by fluorescence and transmission electron microscopy. RESULTS: The most potent arylquinuclidine derivative (3-[1'-{4'-(benzyloxy)-phenyl}]-quinuclidine-2-ene) (WSP1267) had a MIC(50 )of 2 μg/ml for all species tested and MIC(90 )varying from 4 μg/ml to 8 μg/ml. Ultrathin sections of C. albicans treated with 1 μg/ml of WSP1267 showed several ultrastructural alterations, including (a) loss of cell wall integrity, (b) detachment of the plasma membrane from the fungal cell wall, (c) accumulation of small vesicles in the periplasmic region, (d) presence of large electron-dense vacuoles and (e) significantly increased cell size and cell wall thickness. In addition, fluorescence microscopy of cells labelled with Nile Red showed an accumulation of lipid droplets in the cytoplasm of treated yeasts. Nuclear staining with DAPI revealed the appearance of uncommon yeast buds without a nucleus or with two nuclei. CONCLUSION: Taken together, our data demonstrate that arylquinuclidine derivatives could be useful as lead compounds for the rational synthesis of new antifungal drugs. BioMed Central 2011-01-21 /pmc/articles/PMC3036746/ /pubmed/21255433 http://dx.doi.org/10.1186/1476-0711-10-3 Text en Copyright ©2011 Ishida et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Ishida, Kelly
Fernandes Rodrigues, Juliany Cola
Cammerer, Simon
Urbina, Julio A
Gilbert, Ian
de Souza, Wanderley
Rozental, Sonia
Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis
title Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis
title_full Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis
title_fullStr Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis
title_full_unstemmed Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis
title_short Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis
title_sort synthetic arylquinuclidine derivatives exhibit antifungal activity against candida albicans, candida tropicalis and candida parapsilopsis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3036746/
https://www.ncbi.nlm.nih.gov/pubmed/21255433
http://dx.doi.org/10.1186/1476-0711-10-3
work_keys_str_mv AT ishidakelly syntheticarylquinuclidinederivativesexhibitantifungalactivityagainstcandidaalbicanscandidatropicalisandcandidaparapsilopsis
AT fernandesrodriguesjulianycola syntheticarylquinuclidinederivativesexhibitantifungalactivityagainstcandidaalbicanscandidatropicalisandcandidaparapsilopsis
AT cammerersimon syntheticarylquinuclidinederivativesexhibitantifungalactivityagainstcandidaalbicanscandidatropicalisandcandidaparapsilopsis
AT urbinajulioa syntheticarylquinuclidinederivativesexhibitantifungalactivityagainstcandidaalbicanscandidatropicalisandcandidaparapsilopsis
AT gilbertian syntheticarylquinuclidinederivativesexhibitantifungalactivityagainstcandidaalbicanscandidatropicalisandcandidaparapsilopsis
AT desouzawanderley syntheticarylquinuclidinederivativesexhibitantifungalactivityagainstcandidaalbicanscandidatropicalisandcandidaparapsilopsis
AT rozentalsonia syntheticarylquinuclidinederivativesexhibitantifungalactivityagainstcandidaalbicanscandidatropicalisandcandidaparapsilopsis